Blueprint Medicines Corp (BPMC)
106.79
+1.33
(+1.26%)
USD |
NASDAQ |
May 15, 16:00
106.78
0.00 (0.00%)
Pre-Market: 20:00
Blueprint Medicines Market Cap: 6.687B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 15, 2024 | 6.687B |
| May 14, 2024 | 6.604B |
| May 13, 2024 | 6.766B |
| May 10, 2024 | 6.681B |
| May 09, 2024 | 6.784B |
| May 08, 2024 | 6.811B |
| May 07, 2024 | 6.797B |
| May 06, 2024 | 6.653B |
| May 03, 2024 | 6.712B |
| May 02, 2024 | 6.700B |
| May 01, 2024 | 5.940B |
| April 30, 2024 | 5.719B |
| April 29, 2024 | 5.848B |
| April 26, 2024 | 5.842B |
| April 25, 2024 | 5.699B |
| April 24, 2024 | 5.795B |
| April 23, 2024 | 5.797B |
| April 22, 2024 | 5.692B |
| April 19, 2024 | 5.455B |
| April 18, 2024 | 5.584B |
| April 17, 2024 | 5.552B |
| April 16, 2024 | 5.408B |
| April 15, 2024 | 5.351B |
| April 12, 2024 | 5.481B |
| April 11, 2024 | 5.774B |
| Date | Value |
|---|---|
| April 10, 2024 | 5.664B |
| April 09, 2024 | 5.771B |
| April 08, 2024 | 5.730B |
| April 05, 2024 | 5.737B |
| April 04, 2024 | 5.676B |
| April 03, 2024 | 5.773B |
| April 02, 2024 | 5.731B |
| April 01, 2024 | 6.035B |
| March 28, 2024 | 5.808B |
| March 27, 2024 | 5.804B |
| March 26, 2024 | 5.491B |
| March 25, 2024 | 5.402B |
| March 22, 2024 | 5.330B |
| March 21, 2024 | 5.514B |
| March 20, 2024 | 5.404B |
| March 19, 2024 | 5.387B |
| March 18, 2024 | 5.316B |
| March 15, 2024 | 5.542B |
| March 14, 2024 | 5.371B |
| March 13, 2024 | 5.548B |
| March 12, 2024 | 5.493B |
| March 11, 2024 | 5.478B |
| March 08, 2024 | 5.652B |
| March 07, 2024 | 5.636B |
| March 06, 2024 | 5.534B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.278B
Minimum
Feb 24 2023
6.937B
Maximum
Dec 23 2020
4.294B
Average
4.039B
Median
Jun 03 2020
Market Cap Benchmarks
| Ligand Pharmaceuticals Inc | 1.541B |
| Apellis Pharmaceuticals Inc | 5.088B |
| Alnylam Pharmaceuticals Inc | 18.64B |
| Biomarin Pharmaceutical Inc | 15.27B |
| Corcept Therapeutics Inc | 2.897B |
Market Cap Related Metrics
| PS Ratio | 23.26 |
| Price to Book Value | 21.52 |
| Price | 106.79 |
| Earnings Yield | -4.50% |